Pending postmarket study commitments dropping

The FDA says 71% (899) of pending postmarketing study commitments promised by drug sponsors at the time of approval have never been started. This is a worsening trend; in 2005, 65% (797) of pending studies had not been started.

You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory